Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth F Jarrett

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphomaHenrik Hjalgrim, Klaus Rostgaard, Paul C D Johnson, et al.
Plos Biology|December 21, 2021
Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defensesVanessa Herder, Kieran Dee, Joanna K Wojtus, et al.
British Journal of Haematology|October 8, 2016
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohortsHervé Ghesquières, Beth R Larrabee, Olivier Casasnovas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2023
Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related MalignanciesIlona Argirion, Ruth M Pfeiffer, Carla Proietti, et al.
Immunity|July 17, 2012
Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cellsMuzlifah Haniffa, Amanda Shin, Venetia Bigley, et al.
Nature Communications|October 24, 2013
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphomaMatthew Frampton, Miguel Inacio da Silva Filho, Peter Broderick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 26, 2015
A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin LymphomaManon Delahaye-Sourdeix, Kevin Y Urayama, Valérie Gaborieau, et al.
The Journal of Clinical Investigation|May 23, 2023
Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphomaBenedetta Apollonio, Filomena Spada, Nedyalko Petrov, et al.
Nature Communications|December 3, 2017
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibilityAmit Sud, Hauke Thomsen, Philip J Law, et al.
Nature Communications|January 10, 2019
Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibilityAmit Sud, Hauke Thomsen, Philip J Law, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphomaHenrik Hjalgrim, Klaus Rostgaard, Paul C D Johnson, et al.
Plos Biology|December 21, 2021
Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defensesVanessa Herder, Kieran Dee, Joanna K Wojtus, et al.
British Journal of Haematology|October 8, 2016
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohortsHervé Ghesquières, Beth R Larrabee, Olivier Casasnovas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2023
Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related MalignanciesIlona Argirion, Ruth M Pfeiffer, Carla Proietti, et al.
Immunity|July 17, 2012
Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cellsMuzlifah Haniffa, Amanda Shin, Venetia Bigley, et al.
Nature Communications|October 24, 2013
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphomaMatthew Frampton, Miguel Inacio da Silva Filho, Peter Broderick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 26, 2015
A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin LymphomaManon Delahaye-Sourdeix, Kevin Y Urayama, Valérie Gaborieau, et al.
The Journal of Clinical Investigation|May 23, 2023
Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphomaBenedetta Apollonio, Filomena Spada, Nedyalko Petrov, et al.
Nature Communications|December 3, 2017
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibilityAmit Sud, Hauke Thomsen, Philip J Law, et al.
Nature Communications|January 10, 2019
Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibilityAmit Sud, Hauke Thomsen, Philip J Law, et al.
Pageof 6